The impact of corticosteroid use on inpatients with inflammatory bowel disease and positive polymerase chain reaction for Clostridium difficile.

Lim, Huei-Wen; Schuster, Isaiah P; Rajapakse, Ramona; Monzur, Farah; Khan, Sundas; Sultan, Keith

Lim, Huei-Wen; Schuster, Isaiah P; Rajapakse, Ramona; Monzur, Farah; Khan, Sundas; Sultan, Keith.

Afiliação

Lim HW; Division of Gastroenterology and Hepatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA.
Schuster IP; Division of Gastroenterology and Hepatology, Stony Brook University Hospital, Stony Brook, NY, USA.
Rajapakse R; Division of Gastroenterology and Hepatology, Stony Brook University Hospital, Stony Brook, NY, USA.
Monzur F; Division of Gastroenterology and Hepatology, Stony Brook University Hospital, Stony Brook, NY, USA.
Khan S; Division of Gastroenterology and Hepatology, The Feinstein Institute for Medical Research, Manhasset, NY, USA.
Sultan K; Division of Gastroenterology and Hepatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA.

Intest Res ; 17(2): 244-252, 2019 Apr.

Article em En | MEDLINE | ID: mdl-30739437

Palavras-chave

Adverse outcomes; Clostridium difficile; Corticosteroids; Inflammatory bowel disease; Polymerase chain reaction

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Intest Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação:

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google